(VIANEWS) – Albany International Corporation (AIN), Amphastar Pharmaceuticals (AMPH), Rollins (ROL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Albany International Corporation (AIN)
22.9% sales growth and 12.17% return on equity
Albany International Corp. engages in the textile and materials processing businesses. The company operates in two segments, Machine Clothing (MC) and Albany Engineered Composites (AEC). The MC segment designs, manufactures, and markets paper machine clothing for use in manufacturing papers, paperboards, tissues, and towels. This segment offers forming, pressing, and drying fabrics, as well as process belts. It also provides customized and consumable fabrics that are used in the manufacturing process in the pulp, corrugator, nonwovens, fiber cement, building products, tannery, and textile industries. This segment sells its products directly to end-user customers. The AEC segment designs, develops, and manufactures composite structures primarily to customers in the commercial and defense aerospace industries. The company operates in the United States, Switzerland, France, Brazil, China, Mexico, and internationally. Albany International Corp. was founded in 1895 and is headquartered in Rochester, New Hampshire.
Earnings Per Share
As for profitability, Albany International Corporation has a trailing twelve months EPS of $3.55.
PE Ratio
Albany International Corporation has a trailing twelve months price to earnings ratio of 24.85. Meaning, the purchaser of the share is investing $24.85 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.17%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 20.4%, now sitting on 1.15B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 4.4% and positive 6.7% for the next.
Yearly Top and Bottom Value
Albany International Corporation’s stock is valued at $88.23 at 20:22 EST, way under its 52-week high of $99.41 and way higher than its 52-week low of $78.20.
2. Amphastar Pharmaceuticals (AMPH)
19% sales growth and 23.55% return on equity
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Earnings Per Share
As for profitability, Amphastar Pharmaceuticals has a trailing twelve months EPS of $2.6.
PE Ratio
Amphastar Pharmaceuticals has a trailing twelve months price to earnings ratio of 15.99. Meaning, the purchaser of the share is investing $15.99 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.55%.
Volume
Today’s last reported volume for Amphastar Pharmaceuticals is 111888 which is 76.09% below its average volume of 467962.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Amphastar Pharmaceuticals’s EBITDA is 51.65.
3. Rollins (ROL)
10.5% sales growth and 35.91% return on equity
Rollins, Inc., through its subsidiaries, provides pest and wildlife control services to residential and commercial customers in the United States and internationally. The company offers pest control services to residential properties protecting from common pests, including rodents, insects, and wildlife. It also provides workplace pest control solutions for customers across various end markets, such as healthcare, foodservice, and logistics. In addition, the company offers termite protection services and ancillary services. It serves clients directly, as well as through franchisee operations. The company was formerly known as Rollins Broadcasting, Inc and changed its name to Rollins, Inc. in 1965. Rollins, Inc. was founded in 1901 and is headquartered in Atlanta, Georgia.
Earnings Per Share
As for profitability, Rollins has a trailing twelve months EPS of $0.89.
PE Ratio
Rollins has a trailing twelve months price to earnings ratio of 49.83. Meaning, the purchaser of the share is investing $49.83 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 35.91%.
4. Addus HomeCare Corporation (ADUS)
9.4% sales growth and 9.33% return on equity
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.
Earnings Per Share
As for profitability, Addus HomeCare Corporation has a trailing twelve months EPS of $3.83.
PE Ratio
Addus HomeCare Corporation has a trailing twelve months price to earnings ratio of 26.82. Meaning, the purchaser of the share is investing $26.82 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.33%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 12.4% and 7.5%, respectively.
Volume
Today’s last reported volume for Addus HomeCare Corporation is 4044 which is 96.49% below its average volume of 115252.
5. Baidu (BIDU)
6.5% sales growth and 8.61% return on equity
Baidu, Inc. engages in the provision of internet search services in China. It operates through two segments: Baidu Core and iQIYI. The company offers Baidu App to access search, feed, and other services using mobile devices; Baidu Search to access its search and other services; Baidu Feed that provides users with personalized timeline based on their demographics and interests; Baidu Health that helps users to find the doctor and hospital for healthcare needs; and Haokan, a short video app. It also provides Baidu Knows, an online community where users can ask questions to other users; Baidu Wiki; Baidu Experience; Baidu Post; ERNIE Bot, conversational AI bot; Baidu Wenku; Baidu Maps, a voice-enabled mobile app that provides travel-related services; Baidu Drive; Baijiahao; and DuerOS, a smart assistant platform. In addition, it offers online marketing services, which include pay for performance, an auction-based services that allow customers to bid for priority placement of paid sponsored links and reach users who search for information related to their products or services; other marketing services that include display-based marketing services and other online marketing services based on performance criteria other than cost per click; mobile ecosystem, a portfolio of apps, including Baidu App, Haokan, and Baidu Post; various cloud services and solutions, such as platform as a service, software as a service, and infrastructure as a service; self-driving services, including maps, automated valet parking, navigation pilot, electric vehicles, and robotaxi fleets, as well as Xiaodu smart devices. Further, the company provides iQIYI, an online entertainment service, including original and licensed content; other video content and membership; and online advertising services. It has strategic partnership with Zhejiang Geely Holding Group. The company was formerly known as Baidu.com, Inc. Baidu, Inc. was incorporated in 2000 and is headquartered in Beijing, China.
Earnings Per Share
As for profitability, Baidu has a trailing twelve months EPS of $7.62.
PE Ratio
Baidu has a trailing twelve months price to earnings ratio of 12.8. Meaning, the purchaser of the share is investing $12.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.61%.
Volume
Today’s last reported volume for Baidu is 5144180 which is 48.99% above its average volume of 3452590.
